Advance in Gluten-Free Diet

The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes,...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (110 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03455nam-a2200745z--4500
001 993545643704498
005 20231214133057.0
006 m o d
007 cr|mn|---annan
008 202105s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040514 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68320 
035 |a (EXLCZ)995400000000040514 
041 0 |a eng 
100 1 |a Paolo, Usai-Satta  |4 edt 
245 1 0 |a Advance in Gluten-Free Diet 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (110 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
650 7 |a Food & society  |2 bicssc 
653 |a irritable bowel syndrome 
653 |a celiac disease 
653 |a nonceliac gluten/wheat sensitivity 
653 |a gluten-free diet 
653 |a AIDAI score 
653 |a amylase trypsin inhibitor 
653 |a non-celiac wheat sensitivity 
653 |a CD14 lymphocytes 
653 |a interleukin-1beta 
653 |a tumor necrosis factor-α 
653 |a non coeliac wheat sensitivity 
653 |a gluten 
653 |a FODMAPs 
653 |a functional dyspepsia 
653 |a Celiac disease 
653 |a iron deficiency without anemia 
653 |a dietary iron 
653 |a iron supplementation 
653 |a women 
653 |a refractory celiac disease 
653 |a remission 
653 |a nickel allergy 
653 |a allergic contact mucositis 
653 |a irritable bowel syndrome (IBS) 
653 |a low-nickel diet 
653 |a gluten-free products 
653 |a gluten containing products 
653 |a food composition database 
653 |a dietary reference intake 
653 |a prison diets 
653 |a irritable bowel disease 
653 |a FODMAP 
653 |a low FODMAP diet 
653 |a gluten free diet 
653 |a non-celiac gluten wheat sensitivity 
776 |z 3-03943-871-9 
776 |z 3-03943-872-7 
700 1 |a Paolo, Usai-Satta  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:42:09 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338005670004498&Force_direct=true  |Z 5338005670004498  |b Available  |8 5338005670004498